Search
for
Sort by
Research 121–150 of 1000+
- [Cutaneous effects in hormonal contraception].
- Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center
- Clinical and Hormonal Evaluation of Androgen Excess
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study
- A study on the clinical and hormonal profile of patients with hirsutism
- Effect of Metformin Therapy on Clinical and Hormonal Indices of Patients with Polycystic Ovary Syndrome
- CORRELATION OF CUTANEOUS MANIFESTATIONS WITH HORMONAL PROFILE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- Irregular Menstruation, Acne, Hirsutism, and the Possibility with PCOS
- A prospective cross sectional observational study on prevalence of clinical manifestations and hormonal abnormalities associated with polycystic ovarian disease
- Cutaneous Manifestations in Patients with Polycystic Ovary Syndrome: Their Prevalence and Correlation with Hormonal and Metabolic Parameters
- A Study on the Clinical, Hormonal and Gynecological Parameters in Polycystic Ovarian Syndrome
- Dermatologic manifestations in patients with polycystic ovary syndrome: their prevalence and assessment in relation to hormonal and metabolic changes
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Hypothyroidism in polycystic ovarian syndrome: a comparative study of clinical characteristics, metabolic and hormonal parameters in euthyroid and hypothyroid polycystic ovarian syndrome women
- Effects of Laparoscopic Ovarian Drilling on Restoration of Menstrual Cycles, Hormonal Profiles and Pregnancy Rate in Women with Polycystic Ovary Syndrome
- Correlation of cutaneous manifestations with body mass index, blood glucose, and hormonal levels in patients with polycystic ovarian disease
- Sexual Hormones in Human Skin
- Human Skin is a Steroidogenic Tissue: Steroidogenic Enzymes and Cofactors Are Expressed in Epidermis, Normal Sebocytes, and an Immortalized Sebocyte Cell Line (SEB-1)
- Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Flutamide
- Spironolactone
- Patent Evaluation: Δ-4,6-Steroids as Potent 5α-Reductase Inhibitors
- Cutaneous manifestation of polycystic ovary syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic
- Cutaneous immunopathology of androgenetic alopecia